![Meryl Zausner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meryl Zausner
Direktor/Vorstandsmitglied bei Deirdres House
Aktive Positionen von Meryl Zausner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Deirdres House | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Meryl Zausner
Ehemalige bekannte Positionen von Meryl Zausner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SERES THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 30.08.2018 | 22.06.2023 |
Independent Dir/Board Member | 30.08.2018 | 22.06.2023 | |
Goldfinch Bio, Inc.
![]() Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 20.04.2021 | 01.12.2022 |
The Multiple Myeloma Research Foundation, Inc.
![]() The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Direktor/Vorstandsmitglied | 01.01.2008 | 01.06.2021 |
NEON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.12.2017 | 06.05.2020 |
Independent Dir/Board Member | 12.12.2017 | 06.05.2020 | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Finanzdirektor/CFO | 01.01.2008 | 01.06.2017 |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Verwaltungsdirektor | 01.06.2012 | 01.01.2014 |
Finanzdirektor/CFO | 01.06.2012 | 01.01.2014 | |
Corporate Officer/Principal | 01.01.2006 | 01.06.2012 | |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Finanzdirektor/CFO | 01.01.2000 | - |
COLGATE-PALMOLIVE COMPANY | Comptroller/Controller/Auditor | - | - |
Ausbildung von Meryl Zausner
State University of New York at Albany | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Operativ
Director/Board Member | 5 |
Director of Finance/CFO | 3 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 7 |
Consumer Non-Durables | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
COLGATE-PALMOLIVE COMPANY | Consumer Non-Durables |
SERES THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
The Multiple Myeloma Research Foundation, Inc.
![]() The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
BioNTech US, Inc.
![]() BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Goldfinch Bio, Inc.
![]() Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
Deirdres House |
- Börse
- Insiders
- Meryl Zausner
- Erfahrung